Impact of dialysis dependence on survival for multiple myeloma with renal impairment: a multicenter study in China

被引:0
|
作者
Jian, Yuan [1 ]
Zhou, Huixing [1 ]
Xie, Weiwei [2 ]
Ren, Yuan [3 ]
Zhang, Zhiyao [1 ]
Yang, Guangzhong [1 ]
Geng, Chuanying [1 ]
Jia, Jing [1 ]
Chen, Wenming [1 ]
Huang, Wenrong [3 ]
Cen, Xinan [2 ]
Gao, Wen [1 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Myeloma Res Ctr Beijing, Dept Hematol, Beijing, Peoples R China
[2] Peking Univ First Hosp, Dept Hematol, Beijing, Peoples R China
[3] Gen Hosp Peoples Liberat Army, Med Ctr 5, Dept Hematol, Beijing, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2023年 / 13卷 / 04期
基金
北京市自然科学基金;
关键词
Multiple myeloma; renal impairment; dialysis dependence; dialysis independence; survival; DIAGNOSIS; RECOVERY; POPULATION; MORTALITY; FAILURE; OUTCOMES; THERAPY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Renal impairment (RI) is a very common complication of multiple myeloma (MM) with a negative impact on survival. Herein we retrospectively analyzed 334 MM patients with renal impairment at diagnosis from three hospi-tals in China. All 334 patients were divided into three groups, including dialysis dependence (n=43), dialysis inde-pendence (n=42), and without dialysis (n=249). Compared with dialysis independence and without dialysis groups, dialysis dependence group had the lowest overall hematologic response (48.8% vs. 97.6% vs. 77.1%, P<0.001) and overall renal response (0.0% vs. 97.6% vs. 72.7%, P<0.001), as well as the highest early mortality within 24 months (50.0% vs. 24.4% vs. 26.3%, P=0.006). Dialysis dependence group had similar progression-free survival (24 vs. 26 vs. 27 months, P=0.231) and significantly shorter overall survival (25 vs. 69 vs. 45 months, P=0.001). Dialysis dependence was independently associated with high mortality within 24 months and shorter overall survival. In conclusion, MM patients with dialysis dependence still tend to suffer a dismal disease course, including a high probability to suffer early mortality, worse hematological and renal response, as well as shorter survival. Dialysis independence could be very promising for survival improvement.
引用
收藏
页码:1571 / 1581
页数:11
相关论文
共 50 条
  • [1] Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients
    Kleber, Martina
    Ihorst, Gabriele
    Deschler, Barbara
    Jakob, Christian
    Liebisch, Peter
    Koch, Bernd
    Sezer, Orhan
    Engelhardt, Monika
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (06) : 519 - 527
  • [2] Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study
    Antlanger, Marlies
    Dust, Tobias
    Reiter, Thomas
    Boehm, Alexandra
    Lamm, Wolfgang W.
    Gornicec, Max
    Willenbacher, Ella
    Nachbaur, David
    Weger, Roman
    Rabitsch, Werner
    Rasoul-Rockenschaub, Susanne
    Worel, Nina
    Lechner, Daniel
    Greinix, Hildegard
    Keil, Felix
    Gisslinger, Heinz
    Agis, Hermine
    Krauth, Maria-Theresa
    BMC CANCER, 2018, 18
  • [3] Renal impairment at presentation in multiple myeloma continues to be associated with poor survival
    Laing, Alison A.
    Geddes, Colin
    Soutar, Richard
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (06) : 901 - 902
  • [4] Incidence, prognostic impact and clinical outcomes of renal impairment in patients with multiple myeloma: a population-based registry
    Courant, Maxime
    Orazio, Sebastien
    Monnereau, Alain
    Preterre, Julie
    Combe, Christian
    Rigothier, Claire
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (03) : 482 - 490
  • [5] Prognostic impact of 18F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
    Ahn, Seo-Yeon
    Park, Hwa Kyung
    Moon, Joon Ho
    Baek, Dong Won
    Cho, Hee-Jeong
    Sohn, Sang Kyun
    Kang, Sae-Ryung
    Min, Jung-Joon
    Bom, Hee-Seung
    Hong, Chae Moon
    Jeong, Shin Young
    Song, Ga-Young
    Yang, Deok-Hwan
    Ahn, Jae-Sook
    Kim, Hyeoung-Joon
    Jung, Sung-Hoon
    Lee, Je-Jung
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (05) : 668 - 674
  • [6] Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma
    Kobayashi, Hiroki
    Terao, Toshiki
    Tsushima, Takafumi
    Abe, Yoshiaki
    Miura, Daisuke
    Narita, Kentaro
    Kitadate, Akihiro
    Takeuchi, Masami
    Matsue, Kosei
    CANCER MEDICINE, 2020, 9 (12): : 4460 - 4466
  • [7] Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment
    Sharma, Rintu
    Jain, Arihant
    Jandial, Aditya
    Lad, Deepesh
    Khadwal, Alka
    Prakash, Gaurav
    Nada, Ritambhra
    Aggarwal, Ritu
    Ramachandran, Raja
    Varma, Neelam
    Malhotra, Pankaj
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (08) : 626 - 634
  • [8] Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?
    Woziwodzka, Karolina
    Malyszko, Jolanta
    Koc-Zorawska, Ewa
    Zorawski, Marcin
    Dumnicka, Paulina
    Jurczyszyn, Artur
    Batko, Krzysztof
    Mazur, Paulina
    Banaszkiewicz, Malgorzata
    Krzanowski, Marcin
    Golasa, Paulina
    Malyszko, Jacek A.
    Drozdz, Ryszard
    Krzanowska, Katarzyna
    MOLECULES, 2022, 27 (01):
  • [9] The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study
    Oortgiesen, Berdien E.
    Azad, Roshna
    Hemmelder, Marc H.
    Kibbelaar, Robby E.
    Veeger, Nic J. G. M.
    de Vries, Joost C.
    van Roon, Eric N.
    Hoogendoorn, Mels
    HAEMATOLOGICA, 2018, 103 (07) : E311 - E314
  • [10] Clinical and economic burden of medicare beneficiaries with multiple myeloma and renal impairment: An observational study
    Hari, Parameswaran
    Latremouille-Viau, Dominick
    Lin, Peggy
    Guerin, Annie
    Sasane, Medha
    MEDICINE, 2024, 103 (26) : e38609